"The Pharmaceutical Industry's Transition to Electronic Processes"
To reduce inefficiency, FDA encourages pharmaceutical companies to automate processes.
Learn why pharmaceutical companies are discarding their manual, paper-based processes in favor of quality management software systems that allow them to increase efficiency, reduce errors, and save time and resources.
In this white paper you will learn:
A brief history of the FDA’s position on electronic processes and the reasoning behind the shift toward automated processes.
The advantages of electronic processes to pharmaceutical companies of all sizes.
A plan for getting started on the path to process automation.
This white paper can be helpful for pharmaceutical professionals looking to devise a plan for organizing their company’s documents and workflows while simultaneously transitioning to compliant electronic processes.